Call for Abstract
Period for Abstract Submission
From September 1 at noon (JST) to October 29, 2021 at noon (JST)
Abstract submission is now closed.
Thanks to those of you who have submitted abstracts.
Guideline for Abstract Submission
Presentation Type:
- The program committee will decide whether to accept papers and the appropriate presentation type. There are two presentation types; Oral presentation and monitor presentation.
The oral presentation is a general presentation. The presenter has 7 minutes to talk and 3 minutes for discussion.
The monitor presentation is a presentation using your electric poster. The presenter stands beside the monitor on which his/her electric poster (CyPos) appears and discusses the research with interested attendees in the monitor presentation session. The monitor presentation session is for 30 minutes. - The room, date, and time for oral presentation will be notified in the email of acceptance.
- We encourage you to take full advantage of visual aids through the use of computer monitor projection.
Note:
- The JSRT program committee will decide whether to accept your presentation based on your abstract (max. 320 words), which must be submitted by Oct 29, 2021. All decisions are final.
- Withdrawal after January 23, 2022 or no-show to the conference in Yokohama is subject to penalty of acceptance for future meetings and may not be published in the proceedings and the meeting program of the 78th annual meeting of the JSRT.
Submission Details
- Authors are required to disclose conflicts of interest prior to the submission of papers on subject matter of which a company, public agency, or organization has a financial interest (refer to Article 10 of Code of Ethics of the JSRT).
- Please disclose conflicts of interest within your PowerPoint and CyPos presentation materials.
- In the case you are the presenting author on an accepted abstract and you cannot attend the conference, instead of withdrawing, please select a co-author to present the abstract in your place. You must choose at least one substitute presenter for you.
- Please note that on-site presentation is in principle. However, in the case that you are not allowed to travel to Yokohama, a recorded presentation must be uploaded and we may ask you to provide some documents as a proof of travel ban or restrictions.
Presenting Author
Name
- The author’s name should be written completely, avoiding any abbreviation.
- First name and middle initial followed by last/surname.
Membership No.
- Please enter your 7-digit membership number.
- Non-members (Including Supporting members), Now applying for membership
Please leave the text box blank.
Institution/Affiliation
- The institution and affiliation of the presenting author should be written completely, avoiding any abbreviation.
(ex.) The Third Department of Internal Medicine, University of Tokyo, Tokyo, Japan
Address
- The presenting author’s address should be written completely, avoiding any abbreviation.
- Country, Address, Postal/Zip Code, Telephone Number, Extension (if any).
- Email address
- Please note that we do not accept email address with (@hanmail.net or @daum.net) with the system limitations.
- Do not use substitute mail address. Registered email should be unique for each author.
- A confirmation email will be sent to the registered email address automatically when you complete submission.
- If you do not receive a confirmation email from us within 24 hours, please contact us: jsrt@info.email.ne.jp
Co-author(s)
Please add a co-author if necessary (6 or less).
Alternative Presenter
- In the case the registered presenter is unable to attend the meeting, one of the co-author(s) is required to be a presenter instead.
- Please select at least one co-author as the alternative presenter.
- Withdrawal after January 23, 2022 or no-show to the conference without permission in Yokohama is subject to a penalty applied to acceptance for future meetings, and your content may not be published in the proceedings and the meeting program of the 78th Annual Meeting of the JSRT.
Research Category
- Please select a group, a subspecialty, a modality and an organ for your paper. The information is used for an effective and appropriate review process.
Title of Abstract
- Please limit your title to 30 words or less.
(ex.) Molecular mechanism of cardiac hypertrophy induced by hypertension - Do NOT include company name(s), brand name(s), and specific name(s) particularly related to a company.
- You are NOT supposed to list your titles as a series, such as 1st report, 2nd report.
- Avoid using abbreviations except “Examples of abbreviations acceptable for the paper title”
Examples of abbreviations acceptable for the paper title
- Abbreviations that are not included in the PDF document as of October 20, 2012 must be changed to acceptable expressions or spelled out fully.
Abstract Body and A Novelty of Research Statement
- Type your abstract in the box below. We recommend that you write your abstract using word processing software (e.g., MS-word, etc.) then paste it into the box.
- The abstract is limited to 320 words, and should be constructed using the following section heads: Purpose, Methods and Results.
- A Novelty of research statement, not exceeding 200 words, is also required for the review process.
- The novelty statement will be used only in the review process, and will not be shown in the proceedings. Please do not use abbreviations without spelling out words in full on first occurrence.
- You do not need to include an ethical research statement in the abstract, because it will be asked about in the following steps.
A Novelty of Research Statement
- A Novelty of Research Statement is limited to 200 words.
- Do NOT enter the title in the novelty of research statement.
- Do NOT put your name and affiliation in the novelty of research statement.
- Do NOT use abbreviations without spelling out words in full on first occurrence.
Questionnaire about research ethics
- In recognition of ethical issues related to the use of radiation and medication, and/or the causing of mental/material suffering to patients, volunteers, and colleagues, the Japanese Society of Radiological Technology has formulated a set of ethical principles and professional responsibilities to guide researchers’ conduct in their relationships with patients, volunteers, and colleagues.
- Please read JSRT Code of Ethics and answer the following questions about the research ethics of your study.
- If your research includes clinical data (image data, vital information, and private information), volunteers, no papers will be accepted without the approval of IRB.
Conflict of Interest
- All authors are required to disclose conflicts of interest prior to the submission of papers on subject matter of which a company, public agency, or organization has a financial interest (refer to Article 10 of Code of Ethics of the JSRT).
- Please disclose conflicts of interest within your PowerPoint and CyPos presentation materials.
Regulations on withdrawal of abstract
- It is the responsibility of the corresponding first author to complete his/her own presentation.
- Any first author who cannot complete a presentation due to unavoidable reasons must inform the secretariat in advance.
- The co-author should respond instead of the presenters.
- If not, Japanese Society of Radiological Technology will not accept your application for presentation at the Congress for one year.
Password
- Create your View/Update Password.
- You need this password to view or edit your abstract.
Notification of Abstract Acceptance
- A confirmation email will be sent to the registered email address automatically when you complete submission.
- All abstracts submitted for the 78th Annual Meeting of the JSRT are subject to peer review within the program committee after the abstract submission deadline.
- The Committee’s decision will be sent to you by email.
Important Dates
- September 1– October 29, 2021 Abstract Submission
- December 1, 2021 Access to Hotel Accommodation Site Opens
- Late December 2021 Notification of Paper Abstract Acceptance
- Mid-January 2022 Notification of presentation date and time
- February 2022 Electronic poster (CyPos) Submission
ーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーー
All UMIN services will be stopped during the following period.
Please note that abstracts cannot be registered.
October 23, 2021 (Sat) 11: 00-October 24 (Sun) 19:00
(scheduled to stop for 32 hours)
ーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーー
For plaintext communication (non-encrypted communication), go to the following
Contact (Online Registration Inquires)
For any further information about abstract submissions, please contact us by email.
Email: jsrt@info.email.ne.jp
Period for Abstract Submission
From September 1 at noon (JST) to October 29, 2021 at noon (JST)
Abstract submission is now closed.
Thanks to those of you who have submitted abstracts.
Guideline for Abstract Submission
Presentation Type:
- The program committee will decide whether to accept papers and the appropriate presentation type. There are two presentation types; Oral presentation and monitor presentation.
The oral presentation is a general presentation. The presenter has 7 minutes to talk and 3 minutes for discussion.
The monitor presentation is a presentation using your electric poster. The presenter stands beside the monitor on which his/her electric poster (CyPos) appears and discusses the research with interested attendees in the monitor presentation session. The monitor presentation session is for 30 minutes. - The room, date, and time for oral presentation will be notified in the email of acceptance.
- We encourage you to take full advantage of visual aids through the use of computer monitor projection.
Note:
- The JSRT program committee will decide whether to accept your presentation based on your abstract (max. 320 words), which must be submitted by Oct 29, 2021. All decisions are final.
- Withdrawal after January 23, 2022 or no-show to the conference in Yokohama is subject to penalty of acceptance for future meetings and may not be published in the proceedings and the meeting program of the 78th annual meeting of the JSRT.
Submission Details
- Authors are required to disclose conflicts of interest prior to the submission of papers on subject matter of which a company, public agency, or organization has a financial interest (refer to Article 10 of Code of Ethics of the JSRT).
- Please disclose conflicts of interest within your PowerPoint and CyPos presentation materials.
- In the case you are the presenting author on an accepted abstract and you cannot attend the conference, instead of withdrawing, please select a co-author to present the abstract in your place. You must choose at least one substitute presenter for you.
- Please note that on-site presentation is in principle. However, in the case that you are not allowed to travel to Yokohama, a recorded presentation must be uploaded and we may ask you to provide some documents as a proof of travel ban or restrictions.
Presenting Author
Name
- The author’s name should be written completely, avoiding any abbreviation.
- First name and middle initial followed by last/surname.
Membership No.
- Please enter your 7-digit membership number.
- Non-members (Including Supporting members), Now applying for membership
Please leave the text box blank.
Institution/Affiliation
- The institution and affiliation of the presenting author should be written completely, avoiding any abbreviation.
(ex.) The Third Department of Internal Medicine, University of Tokyo, Tokyo, Japan
Address
- The presenting author’s address should be written completely, avoiding any abbreviation.
- Country, Address, Postal/Zip Code, Telephone Number, Extension (if any).
- Email address
- Please note that we do not accept email address with (@hanmail.net or @daum.net) with the system limitations.
- Do not use substitute mail address. Registered email should be unique for each author.
- A confirmation email will be sent to the registered email address automatically when you complete submission.
- If you do not receive a confirmation email from us within 24 hours, please contact us: jsrt@info.email.ne.jp
Co-author(s)
Please add a co-author if necessary (6 or less).
Alternative Presenter
- In the case the registered presenter is unable to attend the meeting, one of the co-author(s) is required to be a presenter instead.
- Please select at least one co-author as the alternative presenter.
- Withdrawal after January 23, 2022 or no-show to the conference without permission in Yokohama is subject to a penalty applied to acceptance for future meetings, and your content may not be published in the proceedings and the meeting program of the 78th Annual Meeting of the JSRT.
Research Category
- Please select a group, a subspecialty, a modality and an organ for your paper. The information is used for an effective and appropriate review process.
Title of Abstract
- Please limit your title to 30 words or less.
(ex.) Molecular mechanism of cardiac hypertrophy induced by hypertension - Do NOT include company name(s), brand name(s), and specific name(s) particularly related to a company.
- You are NOT supposed to list your titles as a series, such as 1st report, 2nd report.
- Avoid using abbreviations except “Examples of abbreviations acceptable for the paper title”
Examples of abbreviations acceptable for the paper title
- Abbreviations that are not included in the PDF document as of October 20, 2012 must be changed to acceptable expressions or spelled out fully.
Abstract Body and A Novelty of Research Statement
- Type your abstract in the box below. We recommend that you write your abstract using word processing software (e.g., MS-word, etc.) then paste it into the box.
- The abstract is limited to 320 words, and should be constructed using the following section heads: Purpose, Methods and Results.
- A Novelty of research statement, not exceeding 200 words, is also required for the review process.
- The novelty statement will be used only in the review process, and will not be shown in the proceedings. Please do not use abbreviations without spelling out words in full on first occurrence.
- You do not need to include an ethical research statement in the abstract, because it will be asked about in the following steps.
A Novelty of Research Statement
- A Novelty of Research Statement is limited to 200 words.
- Do NOT enter the title in the novelty of research statement.
- Do NOT put your name and affiliation in the novelty of research statement.
- Do NOT use abbreviations without spelling out words in full on first occurrence.
Questionnaire about research ethics
- In recognition of ethical issues related to the use of radiation and medication, and/or the causing of mental/material suffering to patients, volunteers, and colleagues, the Japanese Society of Radiological Technology has formulated a set of ethical principles and professional responsibilities to guide researchers’ conduct in their relationships with patients, volunteers, and colleagues.
- Please read JSRT Code of Ethics and answer the following questions about the research ethics of your study.
- If your research includes clinical data (image data, vital information, and private information), volunteers, no papers will be accepted without the approval of IRB.
Conflict of Interest
- All authors are required to disclose conflicts of interest prior to the submission of papers on subject matter of which a company, public agency, or organization has a financial interest (refer to Article 10 of Code of Ethics of the JSRT).
- Please disclose conflicts of interest within your PowerPoint and CyPos presentation materials.
Regulations on withdrawal of abstract
- It is the responsibility of the corresponding first author to complete his/her own presentation.
- Any first author who cannot complete a presentation due to unavoidable reasons must inform the secretariat in advance.
- The co-author should respond instead of the presenters.
- If not, Japanese Society of Radiological Technology will not accept your application for presentation at the Congress for one year.
Password
- Create your View/Update Password.
- You need this password to view or edit your abstract.
Notification of Abstract Acceptance
- A confirmation email will be sent to the registered email address automatically when you complete submission.
- All abstracts submitted for the 78th Annual Meeting of the JSRT are subject to peer review within the program committee after the abstract submission deadline.
- The Committee’s decision will be sent to you by email.
Important Dates
- September 1– October 29, 2021 Abstract Submission
- December 1, 2021 Access to Hotel Accommodation Site Opens
- Late December 2021 Notification of Paper Abstract Acceptance
- Mid-January 2022 Notification of presentation date and time
- February 2022 Electronic poster (CyPos) Submission
ーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーー
All UMIN services will be stopped during the following period.
Please note that abstracts cannot be registered.
October 23, 2021 (Sat) 11: 00-October 24 (Sun) 19:00
(scheduled to stop for 32 hours)
ーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーー
For plaintext communication (non-encrypted communication), go to the following
Contact (Online Registration Inquires)
For any further information about abstract submissions, please contact us by email.
Email: jsrt@info.email.ne.jp
